The OR3A3/OR3A2 antibody is a polyclonal rabbit IgG that recognizes both olfactory receptor family 3 subfamily A members 2 (OR3A2) and 3 (OR3A3). These receptors share structural homology, leading to potential cross-reactivity.
OR3A2 (UniProt: P47893) is encoded by the OR3A2 gene on chromosome 17 and interacts with odorant molecules to initiate neuronal signaling .
OR3A3 (UniProt: Q8NGA8) is a paralog with overlapping epitopes, explaining the antibody’s dual specificity .
OR3A2 protein was detected in the midpiece of human spermatozoa using immunofluorescence, suggesting a role in calcium signaling during chemotaxis .
OR3A3 expression remains less characterized, but cross-reactivity studies indicate its presence in similar cellular compartments .
Ligand activation of OR3A2 induces Ca²⁺ influx in spermatozoa, which is critical for motility and oocyte interaction .
Antibody-based inhibition experiments demonstrated that OR3A2/OR3A3 ligands modulate calcium dynamics via T-type voltage-gated channels (inhibited by mibefradil) .
Western Blotting: Detects OR3A2 at ~35 kDa in transfected Hana3A cells and human sperm lysates .
Immunofluorescence: Localizes OR3A2 to the sperm midpiece and flagella .
ELISA: Quantifies OR3A2/OR3A3 expression levels in biological samples with high sensitivity (EC₅₀: 0.31–0.58 μg/mL) .
Specificity: Validated using Hana3A cells transfected with OR3A2/OR3A3 plasmids .
Cross-Reactivity: Confirmed with peptide-blocking assays, showing reduced signal when pre-incubated with immunogen .
Storage: Stable at -20°C in PBS with 50% glycerol and 0.02% sodium azide .
OR3A3 and OR3A2 (Olfactory Receptor Family 3, Subfamily A, Members 3 and 2) are olfactory receptors with a molecular weight of approximately 34 kDa . While traditionally associated with olfaction, these receptors have been detected in multiple tissues outside the nose, particularly in human spermatozoa, suggesting non-canonical functions .
Research significance:
OR3A3/OR3A2 belongs to a class of ectopically expressed olfactory receptors that may function in chemosensation outside the nasal epithelium
Expression in human spermatozoa suggests potential roles in sperm chemotaxis and oocyte location in the female reproductive tract
Part of an emerging field studying olfactory receptors as chemosensors in non-olfactory tissues
The human genome contains 387 OR genes, with recent transcriptome analyses revealing expression patterns across multiple tissues :
| OR Gene | Tissue Expression | FPKM Values | Expression Confidence |
|---|---|---|---|
| OR3A3 | Human spermatozoa | High/selective | True with high confidence |
| OR2W3 | 20+ different tissues | Variable | >80% true |
| OR6B3 | DRG, TG, retina | High/selective | True with high confidence |
| OR51E2 | Prostate | High | True with high confidence |
Unlike the canonical "one neuron-one receptor" rule in olfactory neurons, multiple ORs can be expressed in the same non-olfactory cell type. OR3A3 is among the more selectively expressed ORs, particularly enriched in sperm cells compared to other tissues .
Validation of OR3A3/OR3A2 antibodies requires a multi-faceted approach following established guidelines :
| Validation Approach | Methodology | Strengths | Considerations |
|---|---|---|---|
| Positive/negative tissue controls | Testing in tissues with known expression patterns | Strong support for well-characterized proteins | Requires known expression pattern |
| Western blot validation | Confirms protein of expected size (34 kDa for OR3A3/OR3A2) | Directly evaluates antibody specificity | Antibodies may perform differently in WB vs. IHC |
| Orthogonal validation | Compare protein detection with mRNA expression (RNA-Seq/RT-PCR data) | Provides correlative evidence | mRNA and protein levels don't always correlate |
| Independent antibody validation | Test multiple antibodies targeting different epitopes | Identical patterns provide strong evidence | Inconsistent results difficult to interpret |
| Recombinant expression | Test in transfected cells expressing OR3A3/OR3A2 | Confirms antibody can detect target protein | Doesn't rule out cross-reactivity in tissues |
Example of orthogonal validation: "We detected OR proteins in various compartments of human spermatozoa... and validated the specificity of OR antibodies using Hana3A cells to express recombinant ORs" .
Based on established reliability criteria for antibody validation , antibodies can be classified into reliability tiers:
| Reliability Score | Definition | Criteria Met |
|---|---|---|
| Enhanced | Meets criteria for enhanced validation | At least one validation method (orthogonal/independent antibody) |
| Supported | Partial validation evidence | RNA consistency without full orthogonal validation or paired antibodies showing similar patterns |
| Approved | Limited validation evidence | RNA consistency but staining pattern inconsistent with literature |
| Uncertain | Insufficient validation | Only multitargeting antibodies available or inconsistent results |
For OR3A3/OR3A2 antibodies, reliability assessment must consider:
High sequence similarity between OR3A3 and OR3A2
Limited literature on expression patterns
Most commercial antibodies target both proteins ("multitargeting")
Based on published methodologies for olfactory receptor localization in sperm :
Sample preparation:
Purify human sperm and incubate in Ringer's solution
Place on poly-L-lysine-coated cover slips
Fix with 4% paraformaldehyde
Immunostaining protocol:
Permeabilize with PBS−/− + 0.1% Triton X-100
Block with PBS−/− + 0.1% Triton X-100, 5% NGS, and 1% fish gelatine (1h)
Incubate with primary OR3A3/OR3A2 antibody (1:50-1:100 dilution) overnight at 4°C
Incubate with Alexa-conjugated secondary antibody and DAPI (45 min, room temperature)
Mount in ProLong Gold
Imaging:
Use confocal fluorescence microscopy for high-resolution localization
Capture multiple focal planes to visualize different sperm compartments (head, midpiece, flagellum)
Example findings: "Immunocytochemical staining of human spermatozoa with antibodies revealed OR protein expression in different regions of human spermatozoa. DAPI staining was used to determine the number and location of the cell nuclei."
Commercial OR3A3/OR3A2 antibodies have been validated for multiple applications :
| Application | Recommended Dilution | Protocol Notes | Detection System |
|---|---|---|---|
| Western blot (WB) | 1:500-1:2000 | Standard SDS-PAGE and transfer procedures | HRP-conjugated secondary antibody |
| Immunofluorescence (IF) | 1:200-1:1000 | Fixation and permeabilization optimization required | Fluorophore-conjugated secondary antibody |
| Immunocytochemistry (ICC) | 1:100-1:500 | Cell-specific protocols may vary | Fluorophore-conjugated secondary antibody |
| ELISA | 1:5000 | Indirect ELISA format | HRP-conjugated secondary antibody |
Important considerations:
Optimization of antibody concentration is essential for each application
Cross-validation between applications strengthens reliability
Include appropriate positive and negative controls for each application
Given the high sequence homology between OR3A3 and OR3A2, most commercial antibodies detect both proteins :
Implications for data interpretation:
Immunodetection reflects combined OR3A3/OR3A2 expression
Cannot distinguish between individual receptor contributions
Results should be reported as "OR3A3/OR3A2" rather than individual receptors
Strategies to differentiate between receptors:
Complement antibody studies with mRNA analysis using receptor-specific primers
Consider mass spectrometry for definitive protein identification
Use bioinformatic approaches to identify unique epitopes for future antibody development
Addressing cross-reactivity in publications:
Clearly state antibody specificity limitations
Report the immunogen sequence used for antibody generation
Discuss alternative interpretations of results given cross-reactivity potential
Detecting olfactory receptors outside the nose presents several challenges :
| Challenge | Cause | Solution |
|---|---|---|
| Low expression levels | Cell-type specific expression in heterogeneous tissues | Enrich for specific cell populations; use sensitive detection methods |
| Potential antisense transcripts | Some OR transcripts exist in antisense orientation | Use strand-specific RNA detection methods; validate protein expression |
| Multiple OR expression | Unlike OSNs, non-olfactory cells may express multiple ORs | Use multiple antibodies; perform co-localization studies |
| Splicing variations | OR transcripts may undergo tissue-specific splicing | Design detection strategies accounting for potential isoforms |
| Expression dynamics | OR expression may change during cellular processes | Temporal studies across development/differentiation |
Example approach: "We used stranded mRNA-Seq and detected a class of putative OR transcripts in an antisense orientation, indicating a different function, rather than coding for a functional OR protein. Nevertheless, we were able to detect OR proteins in various compartments of human spermatozoa, indicating distinct functions."
Deorphanization of olfactory receptors requires systematic approaches :
Heterologous expression system:
Express recombinant OR3A3/OR3A2 in Hana3A cells (specially designed for OR expression)
Co-express with accessory proteins like mRTP1S and Gαolf
Transfection protocol: "Hana3A cells were grown in 35 mm-cell culture dishes (50% confluence) and transfected with the respective OR plasmid (3 μg), and plasmids coding for mRTP1S (0.5 μg) and Gαolf (0.5 μg) for 48h using standard calcium phosphate precipitation technique"
Functional screening:
Confirmation strategies:
Dose-response studies with identified ligands
Structure-activity relationship studies with chemical analogs
Correlation of ligand sensitivity with physiological function
Given the expression of OR3A3/OR3A2 in human spermatozoa, several approaches can investigate their reproductive functions :
Localization studies:
Determine precise subcellular localization in sperm compartments
Compare with other functionally characterized ORs in sperm
Example: "OR proteins OR2H1/2 and OR10J1 are localized to different compartments of human spermatozoa... OR2H1/2 in human spermatozoa... different focus (left, flagellum; right, head)... OR10J1 in human spermatozoa... different focus (left, flagellum and midpiece; right, midpiece)"
Functional assays:
Calcium imaging to detect ligand-induced signaling
Sperm chemotaxis assays with identified ligands
Correlation of receptor activation with sperm motility parameters
Physiological relevance:
Compare OR expression in sperm from fertile versus infertile men
Test receptor blockade effects on sperm function
Investigate potential OR ligands in female reproductive tract fluids
Understanding these receptors could provide insights into reproductive biology and potentially lead to novel fertility treatments or contraceptives.
Recent research on SARS-CoV-2 proteins, particularly ORF3a (not to be confused with OR3A3), may inspire investigation of potential interactions between viral proteins and olfactory receptors :
Potential research questions:
Do olfactory receptors play roles in viral entry or pathogenesis?
Could altered OR signaling contribute to COVID-19 anosmia?
Are there structural similarities between viral proteins and OR ligands?
Experimental approaches:
Co-immunoprecipitation to detect protein-protein interactions
Functional studies in cell culture models
Comparative expression analysis in infected versus non-infected tissues
Technical considerations:
Specificity of antibodies is crucial for distinguishing between viral ORF3a and olfactory receptors
Validation with multiple antibodies targeting different epitopes
Complementary approaches beyond antibody-based detection
This represents a speculative but potentially important research direction given the prominence of olfactory dysfunction in COVID-19.